Manufacturing, Biologic Drugs

Lonza to Invest in Mid-Scale Biologics, Cell Therapy Manufacturing

May 07, 2018

Lonza announces addition of mid-scale biologics manufacturing capacity and cell-therapy suites at Portsmouth, NH site.

Key Ingredients to Healthcare’s Future

May 02, 2018

A skilled workforce is needed to deliver on technology’s promising medical advances.

Consistent API Quality Calls for Collaboration

May 02, 2018

Bioprocess understanding, the right equipment, and automation help, but multifunctional teamwork is the key to API production success.

Patheon Doubles Biologics Capacity at St. Louis Facility

April 23, 2018

Thermo Fisher Scientific invests $50 Million to expand biologics drug development and manufacturing capabilities in St. Louis, MO.

Sanofi Buys Berkeley Lights’ Cell Line Platform

April 20, 2018

The new platform is expected to speed up cell line development.

MilliporeSigma Launches New Single-Use Technologies at INTERPHEX 2018 and Wins Best Tech Award

April 19, 2018

The company unveiled three new products to support single-use biomanufacturing and won an award for best technological innovation at INTERPHEX 2018.

GE Speeds Up Production of Viral Vector-Based Therapeutics

April 17, 2018

The company is launching a new pre-fabricated, ready-to-run manufacturing facility that is expected to significantly decrease the production timeline for viral vector-based therapeutics.

Sartorius Stedim Biotech and Penn State University Announce Biotechnology Partnership

April 16, 2018

Sartorius Stedim Biotech will supply equipment for Penn State’s new Fermentation Facility in the university’s Center of Excellence in Industrial Biotechnology.

Sanofi to Invest Roughly $430 Million in Canadian Vaccine Facility

April 12, 2018

The new facility, to be built in Toronto, Canada, will significantly increase capacity for pediatric and booster vaccines.

Amgen to Build Next-Generation Biomanufacturing Plant

April 11, 2018

The biopharmaceutical firm has chosen Rhode Island as the site of its next-generation biomanufacturing plant, which will offer flexibility, speed, and efficiency.